Telemedicine Is Popular Among Mohs Surgeons – for Now Telemedicine Is Popular Among Mohs Surgeons – for Now
A variety of factors have made it difficult for surgeons to make long-term plans for implementing telemedicine in their practices.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Blood Test for 50 Cancers Coming to US Clinics Soon Blood Test for 50 Cancers Coming to US Clinics Soon
The Galleri blood test, which claims to detect up to 50 different cancers, will be available soon in Washington State; it is already in a pilot trial in the UK.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Follow-up Sinks Candesartan as Cardioprotection in Breast Cancer Follow-up Sinks Candesartan as Cardioprotection in Breast Cancer
The new PRADA findings suggest cardioprotective drugs may not be necessary for all patients during adjuvant breast cancer therapy, the authors say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2021 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

BERENICE: Further Evidence of Heart Safety of Dual HER2 Blockade BERENICE: Further Evidence of Heart Safety of Dual HER2 Blockade
Final results were presented at ESMO Breast Cancer 2021 on dual HER2 blockade with pertuzumab and trastuzumab on top of anthracycline-based neoadjuvant chemotherapy for early-stage breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Inflammasomes' May Play a Role in Obesity-Related CRC'Inflammasomes' May Play a Role in Obesity-Related CRC
Immune system complexes that regulate inflammation have been identified as an important contributor to obesity-related colon cancerMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Health Costs Over 25 Times Higher for Patients With Hemophilia B Health Costs Over 25 Times Higher for Patients With Hemophilia B
As the burden of hemophilia B in patients increases from mild to severe forms of the disease, the already high economic cost of treatment rises significantly, according to a large retrospective database study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Diagnoses Delayed Among Prisoners in Washington State Cancer Diagnoses Delayed Among Prisoners in Washington State
Inmates at Washington state prisons have been diagnosed with cancer, but treatments have been delayed, in some cases leading to terminal illness and death.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Primary Breast Tumors Often Switch HER2 Status on Relapse Primary Breast Tumors Often Switch HER2 Status on Relapse
A substantial proportion of primary breast tumors switch from HER2-0 to HER2-low expression upon relapse, possibly widening the opportunity to treat patients with novel agents.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 11, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Better Survival After Lumpectomy Plus RT vs Mastectomy Better Survival After Lumpectomy Plus RT vs Mastectomy
Breast conservation surgery plus radiotherapy (RT) leads to better outcomes than mastectomy with or without RT for patients with early-stage disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 10, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Early-Onset Colorectal Cancer — Are Sugary Drinks to Blame? Early-Onset Colorectal Cancer — Are Sugary Drinks to Blame?
A new analysis has found that two high-sugar drinks a day in young adulthood was associated with more than double the cancer risk before age 50.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Inclusive' Cancer Research: Don't Reinforce False Perceptions'Inclusive' Cancer Research: Don't Reinforce False Perceptions
Careful language matters because race is a fraught concept.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA OKs Upfront Pembro for Advanced HER2+ Gastric Cancer FDA OKs Upfront Pembro for Advanced HER2+ Gastric Cancer
The accelerated approval is for first-line use in combination with other agents for locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Pediatric Cancer Survivors at Risk for Opioid Misuse Pediatric Cancer Survivors at Risk for Opioid Misuse
Survivors of childhood cancers are at increased risk for prescription opioid misuse compared with their peers, a review of a claims database revealed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Checkpoint Inhibitor Skin Side Effects More Common in Women Checkpoint Inhibitor Skin Side Effects More Common in Women
A small review found a doubling of the odds, but reasons are unclear.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Superior Survival With Sintilimab in Squamous NSCLC Superior Survival With Sintilimab in Squamous NSCLC
Second-line treatment with sintilimab improved survival compared with docetaxel in patients with advanced/metastatic squamous nonsmall cell lung cancer in the phase 3 ORIENT-3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lobaplatin'Promising' in Nasopharyngeal Cancer Lobaplatin'Promising' in Nasopharyngeal Cancer
Lobaplatin-based induction plus chemoradiation was as effective as, and safer than, a cisplatin-based regimen in a phase 3 trial in China.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

One of the Biggest Healthcare Frauds Ever Is Still Ongoing One of the Biggest Healthcare Frauds Ever Is Still Ongoing
Fraudulent cancer genetic testing of senior citizens was the target of a special US strike force 2 years ago, but it did not fully stop the scams.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

JAMA Publishes Trial Results Delayed 5 Years. Here's Why JAMA Publishes Trial Results Delayed 5 Years. Here's Why
The long and winding course to publication of the results of one randomized trial highlights much bigger problems with data ownership, company motivations, and public resources.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 30, 2021 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

Biden Calls for Advanced Research to'End Cancer'Biden Calls for Advanced Research to'End Cancer '
President Joe Biden called on Congress on Wednesday to support the creation of an advanced health research agency that would address the nation's most critical diseases.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

To Stay: Two More Cancer Indications With'Dangling Approvals'To Stay: Two More Cancer Indications With'Dangling Approvals '
On the second day of a historic meeting, FDA advisers voted to keep the accelerated approvals for two immunotherapies for use in bladder cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Single-Cell Sequencing Upends Breast Cancer Assumptions Single-Cell Sequencing Upends Breast Cancer Assumptions
This study turns previous assumptions about the genesis of breast cancers on its head, says Dr Kathy Miller.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA Panel Backs Atezolizumab for mTNBC -- at Least for Now FDA Panel Backs Atezolizumab for mTNBC -- at Least for Now
FDA advisers voted 7-2 for keeping in place an approval for atezolizumab for a kind of metastatic triple-negative breast cancer while urging drugmaker Genentech to continue research on this indication.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Is It Time for Universal Genetic Testing in Colorectal Cancer? Is It Time for Universal Genetic Testing in Colorectal Cancer?
One in six patients with colorectal cancer has an inherited genetic predisposition, but more than half of these are missed with current testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves Loncastuximab for Diffuse Large B-Cell Lymphomas FDA Approves Loncastuximab for Diffuse Large B-Cell Lymphomas
The product is the first and only CD19-targeted antibody drug conjugate (ADC) available for this disease, and was granted an accelerated approval based on overall response rate.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Ellie Guardino, MD, Battled Others' Cancer, Has Died of Her Own Ellie Guardino, MD, Battled Others' Cancer, Has Died of Her Own
Ellie Guardino, MD, PhD, a compassionate physician-scientist, fought through her own diagnosis of metastatic melanoma while contributing to important advances in breast cancer treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EU Panel Likes Azacitidine for AML Maintenance EU Panel Likes Azacitidine for AML Maintenance
The EMA's Committee for Medicinal Products for Human Use adopted a positive opinion of the drug for use as maintenance therapy in patients with acute myeloid leukemia.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves New Immunotherapy for Endometrial Cancer FDA Approves New Immunotherapy for Endometrial Cancer
The accelerated approval for dostarlimab is for use in patients with recurrent or advanced endometrial cancers with deficient mismatch repair (dMMR).FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Timing Important for COVID Vax in Patients With Blood Cancers Timing Important for COVID Vax in Patients With Blood Cancers
Two further studies show that response to COVID-19 vaccination is impaired in patients with blood cancers, but experts still recommended vaccination, because COVID-19 can be deadly in this population.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Teen Tanning Bed Ban Would Prevent Over 15,000 Melanoma Cases Teen Tanning Bed Ban Would Prevent Over 15,000 Melanoma Cases
A ban would cost less than other, well-established public health interventions.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Antibiotics May Prolong PFS in HCC Patients on Immunotherapy Antibiotics May Prolong PFS in HCC Patients on Immunotherapy
Taking antibiotics 30 days before or after starting an immune checkpoint inhibitor was associated with a benefit in progression-free survival (PFS) for patients with hepatocellular carcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Most End-of-Life Care Wishes Met in Older Population: Study Most End-of-Life Care Wishes Met in Older Population: Study
In a cohort of deceased patients aged 65 years or older, nearly 90% felt that the care they had received had been appropriate and in line with their wishes and advance directives.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Tisotumab for Advanced Cervical Cancer Awaiting Approval Tisotumab for Advanced Cervical Cancer Awaiting Approval
The new drug has led to'impressive'responses in patients with recurrent/metastatic cervical cancer whose conditions had progressed after first-line therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First AI Device for Colonoscopy: Extra Set of Expert'Eyes'First AI Device for Colonoscopy: Extra Set of Expert'Eyes '
The GI Genius device, when combined with colonoscopy, enhances provider performance and reduces colon cancer risk by increasing adenoma detection rates.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mycosis Fungoides Hospitalizations Longer for Blacks, Hispanics Mycosis Fungoides Hospitalizations Longer for Blacks, Hispanics
Results are consistent with prior studies that have found Black and Hispanic patients have earlier and more severe disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Tebentafusp improves OS: A First in Metastatic Uveal Melanoma Tebentafusp improves OS: A First in Metastatic Uveal Melanoma
First-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in a phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Dangers of Incentivizing Mediocrity With'Me-Too' Drugs The Dangers of Incentivizing Mediocrity With'Me-Too' Drugs
Dr Jack West warns us about the very real costs of asking so little of pivotal trials for redundant cancer treatments.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Quicker Fertility Rebound in Young Women With Breast Cancer Quicker Fertility Rebound in Young Women With Breast Cancer
Results from a phase 3 trial show that removing cyclophosphamide from the standard chemotherapy regimen improved fertility without compromising survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Made-to-Order TILs Effective Against Metastatic Melanoma Made-to-Order TILs Effective Against Metastatic Melanoma
Cell therapy with tumor-infiltrating lymphocytes (TILs) extracted from tumor tissue yielded responses in patients with heavily pretreated malignant melanoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Combo Shows Benefit Even in Patients With High-Risk HCC New Combo Shows Benefit Even in Patients With High-Risk HCC
Updated data from the IMBRave150 trial show benefit for the combination of atezolizumab with bevacizumab even in patients with high-risk hepatocellular carcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Data Dim Hopes for'Triumph of Drug Discovery'New Data Dim Hopes for'Triumph of Drug Discovery '
Excitement over novel drugs that for the first time showed efficacy against KRAS mutations has been muted somewhat by new data showing many different types of resistance mechanisms.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rankings of Most Common Cancers to Shift Over Next 20 Years Rankings of Most Common Cancers to Shift Over Next 20 Years
Rankings for the most common cancers, as well as the cancer types responsible for the most deaths, are predicted to change over the next 20 years in the United States.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Don't Screen for Vit D in General Population, Says US Task Force Don't Screen for Vit D in General Population, Says US Task Force
There is insufficient evidence that screening for vitamin D deficiency among the asymptomatic general population is of any benefit, concludes an update of US Preventive Services Task Force recommendations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

COVID-19 Vaccine Failure in Patients With Blood Cancers COVID-19 Vaccine Failure in Patients With Blood Cancers
Almost half of patients with hematologic malignancies failed to produce antibodies against SARS-CoV-2 after full vaccination and thus remained at risk for COVID-19 infection.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adverse Reactions to Immunotherapy Can Appear After a Year Adverse Reactions to Immunotherapy Can Appear After a Year
Some cancer patients receiving anti-PD-1 immunotherapy may tolerate the drug well for months but then develop a serious immune-related adverse reaction.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product
Improved survival was seen in a small trial in which a genetically engineered version of herpes simplex virus was infused directly into high-grade gliomas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First AI Device to Detect Colon Lesions FDA Approves First AI Device to Detect Colon Lesions
The GI Genius works in conjunction with an endoscope during colonoscopy, highlighting possible polyps.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 10, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Negative Results When Immunotherapy Was Added Onto Radiation Negative Results When Immunotherapy Was Added Onto Radiation
A phase 3 trial investigating the addition of immunotherapy to avelumab onto chemoradiotherapy in patients with head and neck cancer was stopped early.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 9, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine
Forgoing postoperative radioactive iodine in low-risk differentiated thyroid cancer is supported by phase 3 data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

After 24 Years, Doc Fired by Hospital. Local Uproar Followed. After 24 Years, Doc Fired by Hospital. Local Uproar Followed.
Tom Weiner, MD, has received tremendous support from locals and is fighting back with a lawsuit after being fired from his post for allegedly causing patient harm.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Morning (vs Evening) Dosing and Better Survival in Glioblastoma Morning (vs Evening) Dosing and Better Survival in Glioblastoma
Taking temozolomide in the morning, rather than the evening, was associated with improved survival in some patients with newly diagnosed glioblastoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news